It’s Got a Good Beat and You Can Kill It
By KIM BELLARD Most of us can identify dogs from cats just by the sounds…
It’s Got a Good Beat and You Can Kill It
By KIM BELLARD Most of us can identify dogs from cats just by the sounds they make. We could probably even separate a dog’s bark from a wolf’s howl. If you are a nature lover, you might be able to identify different species of birds by their calls. If you are a cetologist, you might…
CMMI’s Advancing Chronic Care with Effective Scalable Solutions (ACCESS) Model Explained
In May 2025, CMS’s Center for Medicare & Medicaid Innovation (CMMI) unveiled it’s “Make America Healthy Again” vision. CMMI models focus on not only “protecting the federal taxpayer,” but also (i) promoting evidence-based prevention, (ii) empowering people to achieve their health goals, and (iii) driving choice and competition for people. CMMI has introduced a number…
Why Healthcare AI Still Can’t Scale — and How Nvidia & Hoppr Are Trying to Fix It
Nvidia and Hoppr are betting that healthcare AI will scale not through standalone applications, but through a new infrastructure layer that lets providers develop and deploy their own imaging models. The post Why Healthcare AI Still Can’t Scale — and How Nvidia & Hoppr Are Trying to Fix It appeared first on MedCity News.
CEO of For-Profit MA Plan Tells CMS “Pay Us Less”
Ed Park is sincere and passionate about his calling as the CEO of Devoted Health, which provides Medicare Advantage plans to seniors in 29 states. But it remains to be seen if he can do more or the same with less. The post CEO of For-Profit MA Plan Tells CMS “Pay Us Less” appeared first…
Timely by DrFirst Aims to Lower Barriers to Specialty Meds
Timely by DrFirst launched a tool to streamline prior authorizations and improve access to specialty medications. The post Timely by DrFirst Aims to Lower Barriers to Specialty Meds appeared first on MedCity News.
Intellia’s Data Reveal Tees Up FDA Filing for CRISPR-Based In Vivo Gene-Editing Med
Intellia Therapeutics’ lonvo-z uses CRISPR to inactivate a gene in the liver to reduce levels of a protein key to the swelling attacks from the rare disease hereditary angioedema. Intellia has filed a regulatory submission for this genetic medicine, which could become the first in vivo gene-editing therapy to land FDA approval. The post Intellia’s…
Collaborative Develops AI Vendor Disclosure Framework
Health AI Partnership identifies information across five domains that it says health systems should request and vendors should disclose
What Dentistry Is Teaching Healthcare About Operational AI
In dental practices, where reimbursement cycles are tighter and administrative inefficiencies are immediately visible, AI is already being evaluated not for novelty, but for operational impact. The post What Dentistry Is Teaching Healthcare About Operational AI appeared first on MedCity News.
Closer Look: Health System Operating Margin Trends and What’s Behind Them
U.S. hospital and health system finances are entering 2026 in a fragile position, burdened by administrative complexity, cost pressures, widening provider disparities, more and sicker patients, and rising labor costs. Is this just a phase, or will it persist?
House Appropriations Committee Releases FY 2027 National Security, Department of State and Related Programs (NSRP) Appropriations Bill
This budget summary provides an analysis of global health funding amounts provided in the FY 2027 House National Security, Department of State and Related Programs (NSRP) Appropriations Bill.
